NIESWANDT BERNHARD has a total of 12 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are PROTEIMAX BIOTECNOLOGIA LTDA, DIMARCHI RICHARD D and SOPHERION THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | Japan | 1 | |
#6 | Republic of Korea | 1 | |
#7 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Nieswandt Bernhard | 12 |
#2 | Renne Thomas | 4 |
#3 | Stoll Guido | 1 |
Publication | Filing date | Title |
---|---|---|
EP1224942A1 | Use of JAQ1 (monoclonal antibody anti GPVI) as a medicament for the protection against thrombotic diseases |